What is the medical insurance reimbursement policy for Crizotinib in 2025?

Crizotinib is a targeted drug used to treat ALK positive non-small cell lung cancer (NSCLC). It has been officially launched in my country a few years ago and has been included in the national medical insurance directory. As of2025, the drug is still covered by medical insurance, and patients can relieve financial pressure through medical insurance reimbursement. However, the specific reimbursement ratio and out-of-pocket amount after payment still need to be determined according to the local medical insurance policy and hospital implementation standards.

Currently, there are two main specifications of crizotinib in China: 250 mg 60 tablets and 200 mg 60 tablets, with each box selling for more than RMB 10,000. After being reimbursed by medical insurance, the patient's actual payment may be significantly reduced. However, due to different implementation policies in different places, it is recommended that patients go to the local hospital pharmacy or medical insurance department to consult the specific price and reimbursement process to obtain accurate information.

In the international market, the original drug of crizotinib is also expensive, especially in Europe and the United States. Due to the impact of exchange rates and taxes, the price of each box is more than 10,000 yuan. For patients with limited financial ability, long-term medication costs of original drugs are relatively high. As a result, more and more patients are turning to overseas generic drugs as viable alternatives.

Take the generic crizotinib drug produced by Laos Lucius Pharmaceutical Company as an example. Its 250mg*60 tablets are priced at just over 1,000 yuan, and its ingredients are basically the same as the original drug. It has been approved by the Lao Ministry of Health. However, it needs to be reminded that when purchasing overseas generic drugs, you need to carefully choose formal channels to ensure the quality and efficacy of the drugs. At the same time, you must use drugs rationally under the guidance of professional doctors to ensure the safety and effectiveness of treatment.

Reference materials:https://go.drugbank.com/drugs/DB08865